Optimum management of mild esophagitis in Japan.
Sugano
K
K
D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D019468:Disease Management; D004942:Esophagitis, Peptic / Q000150:complications / Q000188:drug therapy*; D015738:Famotidine / Q000627:therapeutic use*; D016481:Helicobacter Infections / Q000150:complications; D016480:Helicobacter pylori / Q000302:isolation & purification; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D007564:Japan; D009853:Omeprazole / Q000627:therapeutic use*; D054328:Proton Pump Inhibitors
D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors; D015738:Famotidine; D009853:Omeprazole